Analyst stock forecast
Larimar Therapeutics, Inc. Stock Forecast and Analyst Price Target
LRMR analyst target range, upside, consensus rating and coverage count.
Direct answer
Larimar Therapeutics, Inc.'s average price target is $14.30.
The target implies +238.1% from the recorded current price, and the consensus rating is Strong Buy.
The verified range is $5.00 to $26.00, with 10 analysts in the current consensus when available.
Forecast evidence checked August 10, 2026.
Get free Larimar Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.23
- Average price target
- $14.30
- High price target
- $26.00
- Low price target
- $5.00
- Target upside
- +238.1%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- August 10, 2026
- Valid through
- August 17, 2026